139 related articles for article (PubMed ID: 15956257)
41. Chemotherapy-induced apoptosis in melanoma cells is p53 dependent.
Li G; Tang L; Zhou X; Tron V; Ho V
Melanoma Res; 1998 Feb; 8(1):17-23. PubMed ID: 9508372
[TBL] [Abstract][Full Text] [Related]
42. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
43. Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives.
Engleka KA; Gitler AD; Zhang M; Zhou DD; High FA; Epstein JA
Dev Biol; 2005 Apr; 280(2):396-406. PubMed ID: 15882581
[TBL] [Abstract][Full Text] [Related]
44. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
45. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line.
Zhu BK; Pruitt SC
Melanoma Res; 2005 Oct; 15(5):363-73. PubMed ID: 16179863
[TBL] [Abstract][Full Text] [Related]
46. GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.
Kubic JD; Mascarenhas JB; Iizuka T; Wolfgeher D; Lang D
Mol Cancer Res; 2012 Aug; 10(8):1065-76. PubMed ID: 22679108
[TBL] [Abstract][Full Text] [Related]
47. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
48. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
[TBL] [Abstract][Full Text] [Related]
49. Apoptosis, Expression of PAX3 and P53, and Caspase Signal in Fetuses with Neural Tube Defects.
Wang L; Lin S; Yi D; Huang Y; Wang C; Jin L; Liu J; Zhang Y; Ren A
Birth Defects Res; 2017 Nov; 109(19):1596-1604. PubMed ID: 28786179
[TBL] [Abstract][Full Text] [Related]
50. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis.
Kondo S; Barnett GH; Hara H; Morimura T; Takeuchi J
Oncogene; 1995 May; 10(10):2001-6. PubMed ID: 7761100
[TBL] [Abstract][Full Text] [Related]
51. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
Wang J; Pabla N; Wang CY; Wang W; Schoenlein PV; Dong Z
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1300-7. PubMed ID: 16849690
[TBL] [Abstract][Full Text] [Related]
52. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
53. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
54. TBX2 expression is regulated by PAX3 in the melanocyte lineage.
Liu F; Cao J; Lv J; Dong L; Pier E; Xu GX; Wang RA; Xu Z; Goding C; Cui R
Pigment Cell Melanoma Res; 2013 Jan; 26(1):67-77. PubMed ID: 23020925
[TBL] [Abstract][Full Text] [Related]
55. p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide.
Strasberg Rieber M; Zangemeister-Wittke U; Rieber M
Clin Cancer Res; 2001 May; 7(5):1446-51. PubMed ID: 11350916
[TBL] [Abstract][Full Text] [Related]
56. Microarray analysis detects novel Pax3 downstream target genes.
Mayanil CS; George D; Freilich L; Miljan EJ; Mania-Farnell B; McLone DG; Bremer EG
J Biol Chem; 2001 Dec; 276(52):49299-309. PubMed ID: 11590174
[TBL] [Abstract][Full Text] [Related]
57. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3.
Milewski RC; Chi NC; Li J; Brown C; Lu MM; Epstein JA
Development; 2004 Feb; 131(4):829-37. PubMed ID: 14736747
[TBL] [Abstract][Full Text] [Related]
58. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
59. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
60. Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
Gibson AA; Harwood FG; Tillman DM; Houghton JA
Clin Cancer Res; 1998 Jan; 4(1):145-52. PubMed ID: 9516963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
